VYNE Therapeutics (VYNE)
(Delayed Data from NSDQ)
$0.30 USD
-0.01 (-1.87%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $0.32 +0.02 (5.19%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth C Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
VYNE Therapeutics Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Drugs industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
VYNE 0.30 -0.01(-1.87%)
Will VYNE be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for VYNE based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for VYNE
VYNE Therapeutics Inc. (VYNE) Reports Q2 Loss, Lags Revenue Estimates
Metagenomi (MGX) Reports Q2 Loss, Tops Revenue Estimates
VYNE: What are Zacks experts saying now?
Zacks Private Portfolio Services
Aquestive Therapeutics (AQST) Reports Q2 Loss, Lags Revenue Estimates
Catalyst Pharmaceutical (CPRX) Q2 Earnings and Revenues Surpass Estimates
VYNE Therapeutics Inc. (VYNE) Reports Q3 Loss, Tops Revenue Estimates
Other News for VYNE
VYNE forms 20 Day Moving Average Resistance on September 20
Hammer Candlestick appears for VYNE after 1.94% move
NR7 appears for VYNE after 0.62% move
VYNE forms 20 Day Moving Average Resistance on September 16
VYNE forms Bollinger Band Squeeze on September 15